NDC 51672-4027-03 - Warfarin Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4027
- Requested NDC
- 51672-4027-03
- Package NDCs from labels
- 51672-4027-1, 51672-4027-3, 51672-4027-7, 51672-4027-0, 51672-4027-03
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-06-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Warfarin Sodium - A-S Medication Solutions | A-S Medication Solutions | 2026-06-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Warfarin Sodium - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-04-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Warfarin Sodium | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2025-06-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Warfarin Sodium - Aidarex Pharmaceuticals LLC | Aidarex Pharmaceuticals LLC | 2014-01-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Warfarin Sodium - Med-Health Pharma, LLC | Med-Health Pharma, LLC | 2012-01-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Warfarin Sodium - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-06-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4027-0 | Warfarin Sodium | 10 in 1 CARTON | TABLET | 10 | 14 | |
| 51672-4027-0 | Warfarin Sodium | 10 in 1 BLISTER PACK | TABLET | 10 | 14 | |
| 51672-4027-1 | Warfarin Sodium | 100 in 1 BOTTLE | TABLET | 100 | 14 | |
| 51672-4027-3 | Warfarin Sodium | 1000 in 1 BOTTLE | TABLET | 1000 | 14 | |
| 51672-4027-7 | Warfarin Sodium | 5000 in 1 BOTTLE | TABLET | 5000 | 14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4027 | WARFARIN SODIUM TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 13 | Current NDC, Legacy NDC, 5 package rows | 20231222_8ad881e0-ca41-42ad-9d7d-eb85b3a30af0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4027-1 | EA - Each | 51672-4027 | d262d5fe-3164-402e-baed-0cad8133a280 | 1 | 2012-07-24 |
| 51672-4027-3 | EA - Each | 51672-4027 | 83304be6-832c-49b7-8982-e835b006b0aa | 1 | 2012-07-24 |
| 51672-4027-7 | EA - Each | 51672-4027 | ee456c11-4bbf-4b87-bb7e-9c8464cc857b | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BMNP ALUMINUM OXIDE | ALUMINUM OXIDE | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a5ad83a-0ecb-21fa-e063-6294a90a1422 | 2026-08-31 | Warnings | LMI26O6933 |
| Warfarin Sodium | WARFARIN | Coupler LLC | 5a5b5e3a-6556-a542-e063-6294a90a6d3f | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 855312 6153CWM0CL |
| Warfarin Sodium | WARFARIN SODIUM | Cardinal Health 107, LLC | 7c4deb97-9966-4c8e-9ba6-bb260b71e130 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | ANDA040301 855312 6153CWM0CL |
| Warfarin Sodium | WARFARIN | Coupler LLC | 598e5e2e-9264-8371-e063-6394a90aaf18 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 855318 6153CWM0CL |
| Lipo-Chord | ACETICUM AC, ACETYLSAL AC, ADRENOCORTICOTROPHIN, ALUMINA, ARSENICUM ALB, BORAGO, CEANOTHUS, CHELIDONIUM MAJ, CHIONANTHUS, CHLORAMPHENICOLUM, CHLORPROMAZINUM, CHOLESTERINUM, CORTISONE ACETICUM, DAMIANA, FOLLICULINUM, FUMARICUM AC, KALI IOD, LYCOPODIUM, NAT SULPHURICUM, NUX VOM, OLEUM MORRHUAE, PETROLEUM, PHENACETINUM, PHOSPHORICUM AC, PHOSPHORUS, PLUMB MET, SACCHARUM OFF, SILICEA, TARAXACUM, THYROIDINUM. | Energetix Corporation | 5c83cbd5-46fb-48a0-a739-ff9c81e7129c | 2026-08-11 | Warnings | LMI26O6933 |
| Vac-Chord | ALUMINA, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BELLADONNA, BOLDO, CALCAREA CARBONICA, CARDUUS MARIANUS, CHAMOMILLA, CHELIDONIUM MAJUS, ECHINACEA, HYDRASTIS CANADENSIS, LECITHIN, LEDUM PALUSTRE, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, MORBILLINUM, PERTUSSINUM, PHYTOLACCA DECANDRA, PYROGENIUM, RHUS TOX, SILICEA, SULPHUR, TARAXACUM OFFICINALE, THUJA OCCIDENTALIS, THYROIDINUM. | Energetix Corporation | 880ea1e6-8d4d-486e-9a8f-9d3158a99667 | 2026-08-11 | Warnings | LMI26O6933 |
| Tox-Chord | ALFALFA, ALUMINA, BENZOICUM AC, CARBONEUM, CETRARIA, FOLLICULINUM, FUCUS, FUMARICUM AC, HEPAR SUIS, KALI CARB, KREOSOTUM, NAT MUR, PARAFFINUM, PETROLEUM, PHOSPHORICUM AC, PHOS, PIX LIQUIDA, PLANTAGO, PLUMB MET, PULSATILLA, RADIUM BROM, RESORCINUM, SALOL, SILICEA, SYMPHYTUM, TABACUM, TEREBINTHINA, THYROIDINUM, TRITICUM, ZINC OXYD. | Energetix Corporation | b06b4794-e5bb-4ccd-87fd-37afca7b0f98 | 2026-08-11 | Warnings | LMI26O6933 |
| MycoCan-Chord | ALUMINA, AVENA SATIVA, BORAX, CANDIDA ALBICANS, CARBOLICUM ACIDUM, CEANOTHUS AMERICANUS, ECHINACEA, GAULTHERIA PROCUMBENS, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, LINUM USITATISSIMUM, LITHIUM CARBONICUM, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PHYTOLACCA DECANDRA, SARCOLACTICUM ACIDUM, SEPIA, SILICEA, SOLIDAGO VIRGAUREA, TELLURIUM METALLICUM, TEUCRIUM MARUM, ZINCUM METALLICUM | Energetix Corporation | 227199f8-a45e-44ff-892d-ade4fefea354 | 2026-08-11 | Warnings | LMI26O6933 |
| Metal-Chord | ALLIUM CEPA, ALLIUM SATIVUM, ALPHA-LIPOICUM ACIDUM, ALUMINA, ARSENICUM METALLICUM, BERBERIS VULGARIS, CADMIUM METALLICUM, CARDUUS MARIANUS, CETRARIA ISLANDICA, CUPRUM METALLICUM, CYSTEINUM, GLYCYRRHIZA GLABRA, HEPAR SUIS, LAPPA MAJOR, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NUX VOMICA, PLANTAGO MAJOR, PLUMBUM METALLICUM, PYRIDOXINUM HYDROCHLORICUM, SELENIUM METALLICUM, STILLINGIA SYLVATICA, THYROIDINUM, TRIFOLIUM PRATENSE, ZINGIBER OFFICINALE | Energetix Corporation | ea4d26a8-acf2-46ed-9a69-df7764cc4cfd | 2026-08-11 | Warnings | LMI26O6933 |
| Warfarin Sodium | WARFARIN SODIUM | REMEDYREPACK INC. | bd6ea120-5d1c-4815-94f2-81e28dc6b7a9 | 2026-08-10 | Boxed warning, Warnings, Adverse reactions | ANDA040301 855318 6153CWM0CL |
| Warfarin Sodium | WARFARIN SODIUM | REMEDYREPACK INC. | 724b0061-f42a-4008-a078-09c800ee9785 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | 855288 6153CWM0CL |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | d7fb4290-ed37-4ed3-ae51-c400191961dc | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 855338 6153CWM0CL |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 51e98fb6-ba76-497e-95d8-fe895ef0b7ed | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 855312 6153CWM0CL |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | a4cf3107-5646-4b91-8aae-94548e4409ef | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 855288 6153CWM0CL |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 2fb8b8d5-f643-4069-8e47-5eae31a8fbc8 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 855344 6153CWM0CL |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 884cdbf6-0a52-4126-8e14-b0d7c9367e33 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 855318 6153CWM0CL |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 8eddba53-19c4-411b-b0d4-cb2f948ba125 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 855296 6153CWM0CL |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 2cbcc99d-9107-4d39-a1e9-e19305de8b5d | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 855302 6153CWM0CL |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 8ee94789-72d2-4c42-9dbd-0501e9767d97 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 855332 6153CWM0CL |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 545ec40d-2db1-4581-b3ec-ce195e5f5400 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 855324 6153CWM0CL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.